Vol.
42
No.
09
March 04, 2016Mar 04, 2016
Free
NCI Developing Mouse Models To Succeed NCI-60 Cell Lines
Cover Story
The NCI-60, a panel of 60 cancer cell lines that have become the Rosetta Stone for the development of anticancer drugs, may be entering its twilight years as NCI develops new, and more expansive, patient-derived xenografts, or PDX models.

Login